-
NHS-Biotin: A Translational Readout for Nanobodies
2026-09-05
Multimeric nanobody engineering can increase avidity and functional versatility, but translation depends on reliable methods to confirm assembly, accessibility, and recovery. This thought-leadership article explains how NHS-Biotin can serve as a low-profile analytical and purification handle alongside peptidisc-assisted protein clustering.
-
Docosahexaenoic Acid: From Lipid Maps to Assays
2026-09-04
Docosahexaenoic Acid (DHA) is not simply an antioxidant supplement; it is a membrane-active lipid that links hippocampal metabolism to synaptic function. This article translates spatial metabolomics findings into better assay design, controls, and interpretation for neuroprotection research.
-
Streptavidin – Cy5 in Breast Cancer Assays
2026-09-04
Streptavidin – Cy5 converts biotinylated antibodies, proteins, and nucleic acid probes into sensitive far-red readouts for imaging and flow cytometry. This guide connects the reagent to USP42–JNK/p38 apoptosis research with practical workflows, assay controls, and troubleshooting strategies.
-
DMH1 Workflows for BMP and Organoid Research
2026-09-03
DMH1 provides a practical route to selectively modulate ALK2-dependent BMP signaling in organoid and cancer workflows. This guide connects pathway readouts with assay-ready handling, dose-finding, and troubleshooting strategies for reproducible research.
-
Protease Inhibitor Cocktail: K4003 Guide
2026-09-03
A scenario-driven laboratory guide to using Protease Inhibitor Cocktail (100X H₂O, EDTA Plus), SKU K4003, for preserving protein measurements after cell or tissue lysis. It explains assay compatibility, EDTA-related limitations, workflow optimization, interpretation, and practical vendor-selection criteria.
-
HRP Rabbit Anti-Goat IgG (H+L) Antibody Workflow
2026-09-02
Build sensitive, reproducible workflows for detecting goat primary antibodies across western blotting, ELISA, dot blotting, and tissue staining. This guide connects practical HRP assay optimization with validation needs highlighted by localized p21 mRNA–LNP research in bladder cancer.
-
VX-702 and the Hidden Kinetics of p38α MAPK
2026-09-02
VX-702 is a selective p38α MAPK inhibitor whose assay behavior depends on ATP competition, activation-loop conformation, and phosphatase-driven signal decay. This guide translates emerging structural biology into better experimental decisions across inflammation, platelet, and cardiovascular research.
-
NF 449 for P2X1 Platelet Assays
2026-09-01
NF 449 is a high-potency purinergic receptor antagonist for dissecting ATP-driven P2X1 signaling from P2Y1- and P2Y12-mediated platelet responses. This guide translates the reference findings into practical aggregation, calcium-flux, collagen-response, and thrombosis workflows, with troubleshooting strategies for selectivity and assay variability.
-
CXCR4 Theranostics in Lymphoma: Evidence and Limits
2026-09-01
This 2026 review frames CXCR4 as a theranostic target in lymphoma by linking receptor-directed PET and SPECT imaging with peptide, radioligand, small-molecule, and antibody therapies. Its main contribution is an integrated interpretation of target biology, imaging specificity, treatment selection, and translational barriers such as physiological uptake and compensatory CXCR7 signaling.
-
Methyl-β-cyclodextrin Workflow Guide
2026-08-31
Methyl-β-cyclodextrin (SKU C6939) provides a controllable way to extract cholesterol and selected lipids from cellular membranes for studies of membrane organization, fluidity, and cholesterol-dependent signaling. It is intended for biochemical and cell membrane research only, not for diagnostic, therapeutic, or medical use, and working concentrations and exposure conditions should be optimized empirically because no directly matched paper evidence is supplied.
-
VER 155008: HSP 70 Inhibitor Workflows
2026-08-30
Build a connected workflow from Hsp70 ATPase biochemistry to apoptosis and cancer cell proliferation inhibition with VER 155008. The approach also uses a TGEV HSC70 study to sharpen assay design while clearly separating mechanistic insight from unvalidated antiviral claims.
-
Proteinase K for DNA and EV Protein Workflows
2026-08-29
Proteinase K combines broad protein digestion with compatibility across detergents, EDTA, and moderate heat, making it a practical choice for genomic DNA purification and nuclease cleanup. Its value also extends to carefully controlled extracellular-vesicle assays, where proteolysis can distinguish surface-associated from protected protein cargo.
-
H-89 for PKA and cAMP Signaling Workflows
2026-08-29
Use H-89 as a time-resolved probe to test whether PKA connects Wnt stimulation with O-GlcNAcylation, glycolytic remodeling, and osteoblast differentiation. This workflow emphasizes concentration controls, acute-versus-chronic treatment windows, and orthogonal validation rather than treating H-89 as definitive genetic proof.
-
(+)-Bicuculline: Practical Lab Workflow
2026-08-28
This guide explains how to prepare, apply, and quality-control (+)-Bicuculline as a GABAA receptor antagonist for controlled neuroscience experiments involving inhibitory synaptic transmission and related signaling readouts. It is intended for scientific research only and should not be used for diagnosis, treatment, or clinical decision-making.
-
Phytol Workflows for RXR Assays and Design
2026-08-28
Build more interpretable Phytol experiments by separating RXR activation from solvent, isomer, metabolism, and GABAergic confounders. A polymer self-assembly study adds a practical screening principle: vary composition and observation time systematically instead of assuming one formulation or readout will be optimal.